Matches in Nanopublications for { <http://www.w3.org/1999/02/22-rdf-syntax-ns#SUBJECT> ?p ?o ?g. }
- SUBJECT label "P < .001 ) for dexamethasone" provenance.
- SUBJECT label "P < .001 ) for dexamethasone" provenance.
- SUBJECT label "P < .001 ) for dexamethasone" provenance.
- SUBJECT label "P < .001 ) for dexamethasone" provenance.
- SUBJECT label "P < .001 ) for dexamethasone" provenance.
- SUBJECT label "P < .001 ) for dexamethasone" provenance.
- SUBJECT label "dexamethasone ( DEX ) dexamethasone ( DEX )" provenance.
- SUBJECT label "dexamethasone ( DEX ) dexamethasone ( DEX )" provenance.
- SUBJECT label "dexamethasone ( DEX ) dexamethasone ( DEX )" provenance.
- SUBJECT label "dexamethasone ( DEX ) dexamethasone ( DEX )" provenance.
- SUBJECT label "dexamethasone ( DEX ) dexamethasone ( DEX )" provenance.
- SUBJECT label "dexamethasone ( DEX ) dexamethasone ( DEX )" provenance.
- SUBJECT label "The efficacy of dexamethasone in preventing mortality in critical Covid-19" provenance.
- SUBJECT label "The efficacy of dexamethasone in preventing mortality in critical Covid-19" provenance.
- SUBJECT label "The efficacy of dexamethasone in preventing mortality in critical Covid-19" provenance.
- SUBJECT label "The efficacy of dexamethasone in preventing mortality in critical Covid-19" provenance.
- SUBJECT label "The efficacy of dexamethasone in preventing mortality in critical Covid-19" provenance.
- SUBJECT label "The efficacy of dexamethasone in preventing mortality in critical Covid-19" provenance.
- SUBJECT label "The efficacy of dexamethasone in preventing mortality in critical Covid-19" provenance.
- SUBJECT label "The efficacy of dexamethasone in preventing mortality in critical Covid-19" provenance.
- SUBJECT label "The efficacy of dexamethasone in preventing mortality in critical Covid-19" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.